Keywords = Spiramycin
| Number of Articles: 18 | ||||
| 1 | Therapeutic potential of coconut and ginger oils in chronic murine toxoplasmosis | |||
| Articles in Press, Accepted Manuscript , Available Online from 30 April 2024 | ||||
| Heba Awaad El Naggar; Mai Abdelsameaa Shehata; Hagar Fathy Abdelmaksoud; Ashraf Barakat; reda abdelhameed; Omnia Sobhi; Ayman Mohamed Ashkar | ||||
| 2 | Spiramycin-chitosan Nanoparticles Decline Parasite Burden and Renovate Patent Histopathological Changes in Liver and Lung in Mice Experimentally Infected with Acute Toxoplasmosis | |||
| Volume 55, Issue 4, July and August 2024, Page 1151-1164 | ||||
| Dalia Osama; Nadia El-Dib; Hala khattab; Hassan Ibrahim; mona khater; Ehab Elmahallawy; Ashraf Mohamed Abdel Khalek Barakat | ||||
| 3 | ASSESMENT OF THE THERAPUTIC EFECT OF LATE AZITHROMYCIN TREATMENT ON CHRONIC MURINE TOXOPLASMOSIS | |||
| Volume 53, Issue 3, December 2023, Page 491-498 | ||||
| GEHAN A. RASHED; MONA E. NASR; ATEF H. ABD EL HAMID; NAGWA S. M. ALY; ASHRAF M. A. BARAKAT; KAWKAB A. AHMED; SAFAA H. YOUSSIF; GHADA H. OMAR | ||||
| 4 | IN VIVO ASSESSMENT OF ROSUVASTATIN EFFICACY ON EXPERIMENTAL MURINE WITH AVIRULENT TOXOPLASMOSIS | |||
| Volume 52, Issue 3, December 2022, Page 443-450 | ||||
| GHADA H. OMAR; ALI E. ALI; AMANY F. ELFKHANY; NORHAN E. FAROUK; NAGAT A. SOLIMAN; AMIRA S. EL-GHANNAM | ||||
| 5 | EFFICACY OF MURINE PLATELET RICH-PLASMA VERSUS SPIRAMYCIN IN TREATMENT OF CHRONIC TOXOPLASMOSIS INFECTED MICE | |||
| Volume 52, Issue 2, August 2022, Page 267-278 | ||||
| SHEREEN M. IBRAHIM; SABAH M. A. MOHAMED; HEBA H. M. FOAAD; HAYTHAM K. AHMAD; ASMAA M. F. AL-GHANDOUR | ||||
| 6 | The therapeutic efficacy of curcumin nanoemulsion versus Spiramycin in Toxoplasma gondii (ME49 strain) chronically infected mice | |||
| Volume 15, Issue 2, August 2022, Page 174-180 | ||||
| Eman Rageh; Sherif M Abaza; Eman El-Gayar; Ashraf Barakat; Maha Alabbassy | ||||
| 7 | ASSESSMENT OF POSSIBLE SYNERGISTIC EFFECT OF BISPHOSPHONATES AND STATINS IN MURINE EXPERIMENTAL TOXOPLASMOSIS GONDII | |||
| Volume 51, Issue 3, December 2021, Page 577-584 | ||||
| NADA R. MOHAMED; AZZA I. H. YOUNIS; RABAB S. ZALAT; NAGLAA F.A. IMAM | ||||
| 8 | EFFECT OF NITRIC OXIDE IN CHRONIC EXPERIMENTAL TOXOPLASMA GONDII INFECTION: HISTOPATHOLOGICAL AND HISTOCHEMICAL STUDY | |||
| Volume 27, Issue 5, September 2021, Page 938-947 | ||||
| Marwa Omar; Beessa Abaza El-Sayed Abaza; Esraa Mousa; Hayam Elsaid Rashed; Tahani Ismail Farag | ||||
| 9 | Histopathological and biochemical assessment of the therapeutic effect of gold nanoparticles on experimental chronic toxoplasmosis | |||
| Volume 14, Issue 2, August 2021, Page 171-177 | ||||
| Manal GabAllah; Ashraf Barakat; Noha Ahmed; Nada El-Nadi | ||||
| 10 | Determination of Spiramycin and Oxytetracycline in binary mixtures by novel spectrophotometric methods with and without regression equation | |||
| Volume 58, 1&2, December 2020, Page 53-61 | ||||
| Afaf Abou El Khaira; Hanaa Saleh; magda el henawee; Neven Ahmed; Emad M. Hussien | ||||
| 11 | EFFICACY OF AZITHROMYCIN ON EXPERIMENTAL TOXOPLASMOSIS INFECTED MICE | |||
| Volume 50, Issue 2, August 2020, Page 293-299 | ||||
| MONA E. NASR; ATEF H. ABD EL HAMID; NAGWA S. M. ALY; GHADA H. OMAR; ASHRAF M. A. BARAKAT; KAWKAB A. AHMED; SAFAA H. YOUSSIF; GEHAN A. RASHED | ||||
| 12 | Assessment of Nitrofurantoin Efficacy on Treatment of Murine Model of Toxoplasmosis | |||
| Volume 5, Issue 2 part (2), February 2020, Page 253-256 | ||||
| K.F. Abdallah; M.H. Saleh; S.M. Kishik; B.T. Ali; A.A. El Kholy | ||||
| 13 | ASSESSMENT THE IMPACT OF THE USE OF POLYMER NPs IN TREATMENT OF EXPERIMENTAL MURINE TOXOPLASMOSIS | |||
| Volume 1, Issue 3, 2019, Page 1-22 | ||||
| 14 | The Outcomes of Mesenchymal Stem Cells Therapy for Experimental Toxoplasmosis | |||
| Volume 12, Issue 1, April 2019, Page 34-44 | ||||
| Samia El-Sayed Etewa; Abd-Allah Al-Sayed Al-Hoot; Shimaa Mohamed Abdelmoaty; Samira Metwally Mohammad; Howayda Said Fouad Moawad; Mohamed Hassan Sarhan; Sara Ahmed Abd El-Rahman; Mahmoud Abd El-Aaty El-Shafey; Eman Zakaria Abd El-Monem | ||||
| 15 | ARTESUNATE LOADED NANOFIBER AND ITS COMBINATIONS WITH SPIRAMYCIN FOR TREATMENT OF MURINE TOXOPLASMOSIS | |||
| Volume 49, Issue 1, April 2019, Page 135-144 | ||||
| ENAS F. ABDEL HAMED; NAHED E. MOSTAFA; AMIRA A. SALEH; MARWA A. SALAMA; SHEREEN M. IBRAHIM; SAID M. AHMED; HAYAM E. RASHED | ||||
| 16 | A Study on The Teratogenic Effect of Spiramycin in Albino Rats. | |||
| Volume 35, Issue 2, December 2018, Page 354-363 | ||||
| A.A.A El-Komy; Amany Abd-El-Baky; Heba Abo-el-Ezz, | ||||
| 17 | IN VIVO ASSESSMENT OF THE EFFECTS OF METHOTREXATE ON LATENT TOXOPLASMOSIS | |||
| Volume 47, Issue 3, December 2017, Page 589-598 | ||||
| SAMIA E. ETEWA; DALIA A. ABO EL-MAATY; MAI E. ABD EL-AZEEM; MAHMOUD A. EL-SHAFEY; MOHAMED H. SARHAN; EMAN H. ABDEL BARY; EMAN SAAD | ||||
| 18 | IMMUNOTHERAPEUTIC EFFECT OF SPIRAMYCIN IN EXPERIMENTAL GIARDIASIS | |||
| Volume 46, Issue 1, April 2016, Page 19-25 | ||||
| HOWAIDA I.H. ISMAIL; HASSAN T. SHEIR | ||||
| | ||||
View on SCiNiTO